By Michael Erman and Mrinalika Roy Jan 21 (Reuters) - Johnson & Johnson on Wednesday forecast 2026 sales and profit ahead of ...
Johnson & Johnson is set to report its Q4 results on Wednesday, facing one of the most important transitions in its modern ...
Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.
Ustekinumab had a market value of approximately $17.1 billion for the 12 months ending December 2024, per IQVIA. Hikma is acquiring Insys' unit dose nasal and sublingual spray manufacturing equipment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results